home / stock / brsyf / brsyf news

BRSYF News and Press, Brainsway Ltd Ord

Stock Information
Company Name: Brainsway Ltd Ord
Stock Symbol: BRSYF
Market: OTC
Website: brainsway.com
Menu
BRSYF BRSYF Quote BRSYF Short BRSYF News BRSYF Articles BRSYF Message Board
Get BRSYF Alerts

News, Short Squeeze, Breakout and More Instantly...
BRSYF - BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada

BURLINGTON, Mass. and JERUSALEM, June 17, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced its broad market...
BRSYF - BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS(TM) for Depression

BURLINGTON, Mass. and JERUSALEM, June 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the initiation o...

BRSYF - BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression

BURLINGTON, Mass. and JERUSALEM, June 03, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that the US Food...

BRSYF - BrainsWay Ltd. (BWAY) Q1 2024 Earnings Call Transcript

2024-05-08 13:16:07 ET BrainsWay Ltd. (BWAY) Q1 2024 Earnings Conference Call May 08, 2024 8:30 AM ET Company Participants Troy Williams – Investor Relations, Life Science Advisors Hadar Levy – Chief Executive Officer Ido Marom – Chief Financ...
BRSYF - BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights

Generated Significant 37% Year-over-Year Revenue Growth in Q1 2024 Recorded Positive Quarterly Net Income for Second Consecutive Quarter, and Positive Adjusted EBITDA and Cash Flow from Operations for Third Consecutive Quarter Conference Call to be Held Today at 8:30 AM ET ...

BRSYF - BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024

BURLINGTON, Mass. and JERUSALEM, April 24, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will re...

BRSYF - BrainsWay Expands Deep TMS(TM) Access in Israel Following Significant Increase in Reimbursement Rates

BURLINGTON, Mass. and JERUSALEM, April 17, 2024 (GLOBE NEWSWIRE) --  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the furth...
BRSYF - BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS(TM) to Treat Parkinson's Disease

JERUSALEM and BURLINGTON, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced results published in ...

BRSYF - BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis

JERUSALEM and BURLINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced positive results in a...

BRSYF - BrainsWay Broadens Partnership with Katie's Way Plus Through Order of an Additional 18 Deep TMS(TM) Systems

BURLINGTON, Mass. and JERUSALEM, March 18, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced today that its signif...
Next 10